Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Shifting imaging targets in multiple sclerosis: from inflammation to neurodegeneration.
Vigeveno RM, Wiebenga OT, Wattjes MP, Geurts JJ, Barkhof F. Vigeveno RM, et al. Among authors: wiebenga ot. J Magn Reson Imaging. 2012 Jul;36(1):1-19. doi: 10.1002/jmri.23578. J Magn Reson Imaging. 2012. PMID: 22696123 Review.
Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis.
Klauser AM, Wiebenga OT, Eijlers AJ, Schoonheim MM, Uitdehaag BM, Barkhof F, Pouwels PJ, Geurts JJ. Klauser AM, et al. Among authors: wiebenga ot. Mult Scler. 2018 Apr;24(4):491-500. doi: 10.1177/1352458517702534. Epub 2017 Apr 13. Mult Scler. 2018. PMID: 28406063
Longitudinal absolute metabolite quantification of white and gray matter regions in healthy controls using proton MR spectroscopic imaging.
Wiebenga OT, Klauser AM, Nagtegaal GJ, Schoonheim MM, Barkhof F, Geurts JJ, Pouwels PJ. Wiebenga OT, et al. NMR Biomed. 2014 Mar;27(3):304-11. doi: 10.1002/nbm.3063. Epub 2014 Jan 7. NMR Biomed. 2014. PMID: 24399803
Subcortical atrophy and cognition: sex effects in multiple sclerosis.
Schoonheim MM, Popescu V, Rueda Lopes FC, Wiebenga OT, Vrenken H, Douw L, Polman CH, Geurts JJ, Barkhof F. Schoonheim MM, et al. Among authors: wiebenga ot. Neurology. 2012 Oct 23;79(17):1754-61. doi: 10.1212/WNL.0b013e3182703f46. Epub 2012 Sep 26. Neurology. 2012. PMID: 23019265
White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.
Wiebenga OT, Schoonheim MM, Hulst HE, Nagtegaal GJ, Strijbis EM, Steenwijk MD, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ. Wiebenga OT, et al. AJNR Am J Neuroradiol. 2016 Jun;37(6):1030-7. doi: 10.3174/ajnr.A4690. Epub 2016 Mar 10. AJNR Am J Neuroradiol. 2016. PMID: 26965463 Free article.
Changes in functional network centrality underlie cognitive dysfunction and physical disability in multiple sclerosis.
Schoonheim MM, Geurts J, Wiebenga OT, De Munck JC, Polman CH, Stam CJ, Barkhof F, Wink AM. Schoonheim MM, et al. Among authors: wiebenga ot. Mult Scler. 2014 Jul;20(8):1058-65. doi: 10.1177/1352458513516892. Epub 2013 Dec 17. Mult Scler. 2014. PMID: 24347184
Enhanced axonal metabolism during early natalizumab treatment in relapsing-remitting multiple sclerosis.
Wiebenga OT, Klauser AM, Schoonheim MM, Nagtegaal GJ, Steenwijk MD, van Rossum JA, Polman CH, Barkhof F, Pouwels PJ, Geurts JJ. Wiebenga OT, et al. AJNR Am J Neuroradiol. 2015 Jun;36(6):1116-23. doi: 10.3174/ajnr.A4252. Epub 2015 Mar 5. AJNR Am J Neuroradiol. 2015. PMID: 25742985 Free article. Clinical Trial.
Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis.
Wiebenga OT, Hulst HE, Kooi EJ, Killestein J, Geurts JJ. Wiebenga OT, et al. Neurology. 2011 Nov 29;77(22):1998; author reply1999-2000. doi: 10.1212/WNL.0b013e318239c242. Neurology. 2011. PMID: 22123783 No abstract available.
Transient suppression of MLH1 allows effective single-nucleotide substitution by single-stranded DNA oligonucleotides.
Dekker M, de Vries S, Aarts M, Dekker R, Brouwers C, Wiebenga O, de Wind N, Cantelli E, Tonelli R, Te Riele H. Dekker M, et al. Mutat Res. 2011 Oct 1;715(1-2):52-60. doi: 10.1016/j.mrfmmm.2011.07.008. Epub 2011 Jul 27. Mutat Res. 2011. PMID: 21801734
Feedback